BACKGROUND:Pulmonary vein (PV) isolation has disappointing results in patients with obesity, heart failure, obstructive sleep apnea (OSA) and enlarged left atria (LA), for unclear reasons. We hypothesized that these comorbidities may cause higher numbers or non-PV locations of atrial fibrillation (AF) sources, where targeted source ablation (focal impulse and rotor modulation [FIRM]) should improve the single-procedure success of ablation. METHODS: The Conventional Ablation of AF With or Without Focal Impulse and Rotor Modulation (CONFIRM) trial prospectively enrolled 92 patients at 107 AF ablation procedures, in whom computational mapping identified AF rotors or focal sources. Patients underwent FIRM plus conventional ablation (FIRM-guided), or conventional ablation only, and were evaluated for recurrent AF quarterly with rigourous, often implanted, monitoring. We report the n = 73 patients undergoing first ablation in whom demographic information was available (n = 52 conventional, n = 21 FIRM-guided). RESULTS: Stable sources for AF were found in 97.1% of patients. The numbers of concurrent sources per patient (2.1 ± 1.1) rose with LA diameter (P = 0.021), lower left ventricular ejection fraction (P = 0.039), and the presence of OSA (P = 0.002) or hypomagnesemia (P = 0.017). Right atrial sources were associated with obesity (body mass index ≥ 30; P = 0.015). In patients with obesity, hypertension, OSA, and LA diameter > 40 mm, single-procedure freedom from AF was > 80% when FIRM-guided was used vs. < 50% when conventional ablation was used (all; P < 0.05). CONCLUSIONS: Patients with "difficult to treat" AF exhibit more concurrent AF sources in more widespread biatrial distributions than other patients. These mechanisms explain the disappointing results of PV isolation, and how FIRM can identify patient-specific AF sources to enable successful ablation in this population.
RCT Entities:
BACKGROUND: Pulmonary vein (PV) isolation has disappointing results in patients with obesity, heart failure, obstructive sleep apnea (OSA) and enlarged left atria (LA), for unclear reasons. We hypothesized that these comorbidities may cause higher numbers or non-PV locations of atrial fibrillation (AF) sources, where targeted source ablation (focal impulse and rotor modulation [FIRM]) should improve the single-procedure success of ablation. METHODS: The Conventional Ablation of AF With or Without Focal Impulse and Rotor Modulation (CONFIRM) trial prospectively enrolled 92 patients at 107 AF ablation procedures, in whom computational mapping identified AF rotors or focal sources. Patients underwent FIRM plus conventional ablation (FIRM-guided), or conventional ablation only, and were evaluated for recurrent AF quarterly with rigourous, often implanted, monitoring. We report the n = 73 patients undergoing first ablation in whom demographic information was available (n = 52 conventional, n = 21 FIRM-guided). RESULTS: Stable sources for AF were found in 97.1% of patients. The numbers of concurrent sources per patient (2.1 ± 1.1) rose with LA diameter (P = 0.021), lower left ventricular ejection fraction (P = 0.039), and the presence of OSA (P = 0.002) or hypomagnesemia (P = 0.017). Right atrial sources were associated with obesity (body mass index ≥ 30; P = 0.015). In patients with obesity, hypertension, OSA, and LA diameter > 40 mm, single-procedure freedom from AF was > 80% when FIRM-guided was used vs. < 50% when conventional ablation was used (all; P < 0.05). CONCLUSIONS:Patients with "difficult to treat" AF exhibit more concurrent AF sources in more widespread biatrial distributions than other patients. These mechanisms explain the disappointing results of PV isolation, and how FIRM can identify patient-specific AF sources to enable successful ablation in this population.
Authors: Sanjiv M Narayan; David E Krummen; Kalyanam Shivkumar; Paul Clopton; Wouter-Jan Rappel; John M Miller Journal: J Am Coll Cardiol Date: 2012-07-18 Impact factor: 24.094
Authors: Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; José Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber Journal: Heart Rhythm Date: 2012-03-01 Impact factor: 6.343
Authors: Sanghamitra Mohanty; Prasant Mohanty; Luigi Di Biase; Rong Bai; Agnes Pump; Pasquale Santangeli; David Burkhardt; Joseph G Gallinghouse; Rodney Horton; Javier E Sanchez; Shane Bailey; Jason Zagrodzky; Andrea Natale Journal: J Am Coll Cardiol Date: 2012-04-03 Impact factor: 24.094
Authors: Kalyanam Shivkumar; Kenneth A Ellenbogen; John D Hummel; John M Miller; Jonathan S Steinberg Journal: J Cardiovasc Electrophysiol Date: 2012-11-06
Authors: Abigail May Khan; Steven A Lubitz; Lisa M Sullivan; Jenny X Sun; Daniel Levy; Ramachandran S Vasan; Jared W Magnani; Patrick T Ellinor; Emelia J Benjamin; Thomas J Wang Journal: Circulation Date: 2012-11-21 Impact factor: 29.690
Authors: Sanjiv M Narayan; Tina Baykaner; Paul Clopton; Amir Schricker; Gautam G Lalani; David E Krummen; Kalyanam Shivkumar; John M Miller Journal: J Am Coll Cardiol Date: 2014-03-13 Impact factor: 24.094
Authors: Luther Swift; Daniel A B Gil; Rafael Jaimes; Matthew Kay; Marco Mercader; Narine Sarvazyan Journal: Circ Arrhythm Electrophysiol Date: 2014-08-20
Authors: David E Krummen; Shrinivas Hebsur; Jon Salcedo; Sanjiv M Narayan; Gautam G Lalani; Amir A Schricker Journal: Curr Treat Options Cardiovasc Med Date: 2015-04
Authors: Tina Baykaner; Albert J Rogers; Gabriela L Meckler; Junaid Zaman; Rachita Navara; Miguel Rodrigo; Mahmood Alhusseini; Christopher A B Kowalewski; Mohan N Viswanathan; Sanjiv M Narayan; Paul Clopton; Paul J Wang; Paul A Heidenreich Journal: Circ Arrhythm Electrophysiol Date: 2018-05
Authors: D George Wyse; Isabelle C Van Gelder; Patrick T Ellinor; Alan S Go; Jonathan M Kalman; Sanjiv M Narayan; Stanley Nattel; Ulrich Schotten; Michiel Rienstra Journal: J Am Coll Cardiol Date: 2014-02-12 Impact factor: 24.094
Authors: Niels Voigt; Jordi Heijman; Qiongling Wang; David Y Chiang; Na Li; Matthias Karck; Xander H T Wehrens; Stanley Nattel; Dobromir Dobrev Journal: Circulation Date: 2013-11-18 Impact factor: 29.690
Authors: Tina Baykaner; Gautam G Lalani; Amir Schricker; David E Krummen; Sanjiv M Narayan Journal: J Interv Card Electrophysiol Date: 2014-03-20 Impact factor: 1.900